Through advances in genome technology and informatics, partial and whole genome sequencing have become a routine part of healthcare and research. However, questions and challenges remain:
• When should genome sequencing be carried out, in patients and in healthy individuals?
• What are the aims of genome-based testing in cancer diagnostics, risk prediction, early detection and cancer stratification?
• Has the knowledge derived from cancer genomes & liquid biopsy research progressed beyond the stage of clinical trials?
• Are the analytical tools for sequence interpretation sufficient for optimal healthcare delivery?
• Is the clinical and scientific workforce prepared for genome-based testing?
Organised jointly by the Scottish Genomes Partnership, Genomics England and the British Society for Genetic Medicine, with an outstanding faculty of national and international speakers, Genomic Medicine – Moving Beyond the Sequence will address these questions and discuss the state of the art in Genomic Medicine. Satellite meetings entitled Genetics, Genomics and the Law (June 29th) and Genomic Medicine – Health Economics (July 1st) will provide further context and discussion.
For general enquiries email email@example.com
Register for the events below. Please note, these meetings have been postponed due to the Covid-19 pandemic. We will re-schedule the meetings in due course.